HRH3 and narcolepsy: So far, only one H3R ligand, pitolisant, has entered the market as Wakix, a drug for the treatment of narcolepsy (EMA-2016, FDA-2019) [12] and as Ozawade (EMA-2021) for excessive daytime sleepiness associated with obstructive sleep apnea [13].